Skip to content

Advertisement

  • Study protocol
  • Open Access
  • Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer

  • 1Email author,
  • 2,
  • 3,
  • 4,
  • 2,
  • 2,
  • 5,
  • 6,
  • 1,
  • 1,
  • 1,
  • 2 and
  • 1
BMC Cancer201717:494

https://doi.org/10.1186/s12885-017-3458-3

Received: 26 January 2017

Accepted: 26 June 2017

Published: 21 July 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
26 Jan 2017 Submitted Original manuscript
6 Mar 2017 Author responded Author comments - Danielle Crawley
Resubmission - Version 2
6 Mar 2017 Submitted Manuscript version 2
Publishing
26 Jun 2017 Editorially accepted
21 Jul 2017 Article published 10.1186/s12885-017-3458-3

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Division of Cancer Studies, Cancer Epidemiology Group, Research Oncology, King’s College London, London, UK
(2)
Guy’s and St Thomas’ NHS Foundation Trust, London, UK
(3)
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
(4)
Division of Cancer Studies, King’s College London, London, UK
(5)
Division of Imaging Sciences and Biomedical Engineering, King’s College London, London, UK
(6)
Royal Marsden NHS Foundation Trust, London, UK

Advertisement